Neonatal Hyperbilirubinemia, Seizures, and Opioid Withdrawal

A yellow newborn, a twitching newborn, and an inconsolable newborn may look like separate routine problems, but each can signal a rapidly changing neurologic or metabolic threat. The nurse's first task is to identify what the infant is doing, not to attach a label too early. Unconjugated bilirubin rises when red blood cell breakdown produces more bilirubin than the immature newborn liver can process and excrete. High levels can enter brain tissue and cause acute bilirubin encephalopathy. Seizures may result from hypoglycemia, hypocalcemia, infection, hypoxic-ischemic injury, intracranial disease, or withdrawal-related instability. Opioid withdrawal reflects central nervous system adaptation after prenatal exposure; the infant may have tremors, hypertonia, poor coordination of sucking and swallowing, gastrointestinal losses, and difficulty settling. These conditions overlap. Poor feeding may be caused by jaundice-related lethargy, withdrawal, sepsis, hypoglycemia, or seizure activity. A tremulous infant may be withdrawing, hypoglycemic, cold, or jittery rather than seizing. A newborn who becomes difficult to arouse after phenobarbital may be sedated, hypoxic, or deteriorating from the original illness. The pattern, trend, and response to an intervention determine priority.